LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Innate immune induction and influenza protection elicited by a response-selective agonist of human C5a.

    Sanderson, Sam D / Thoman, Marilyn L / Kis, Kornelia / Virts, Elizabeth L / Herrera, Edgar B / Widmann, Stephanie / Sepulveda, Homero / Phillips, Joy A

    PloS one

    2012  Volume 7, Issue 7, Page(s) e40303

    Abstract: ... fungal infection. We have developed a response-selective agonist of human C5a, termed EP67, which retains ... both prophylactic and therapeutic protection when tested in a murine model of influenza A infection. Mice treated ... of innate immune effector cells, including neutrophils, NK cells, and dendritic cells. EP67 exhibits ...

    Abstract The anaphylatoxin C5a is an especially potent mediator of both local and systemic inflammation. However, C5a also plays an essential role in mucosal host defense against bacterial, viral, and fungal infection. We have developed a response-selective agonist of human C5a, termed EP67, which retains the immunoenhancing activity of C5a at the expense of its inflammatory, anaphylagenic properties. EP67 insufflation results in the rapid induction of pulmonary cytokines and chemokines. This is followed by an influx of innate immune effector cells, including neutrophils, NK cells, and dendritic cells. EP67 exhibits both prophylactic and therapeutic protection when tested in a murine model of influenza A infection. Mice treated with EP67 within a twenty-four hour window of non-lethal infection were significantly protected from influenza-induced weight loss. Furthermore, EP67 delivered twenty-four hours after lethal infection completely blocked influenza-induced mortality (0% vs. 100% survival). Since protection based on innate immune induction is not restricted to any specific pathogen, EP67 may well prove equally efficacious against a wide variety of possible viral, bacterial, and fungal pathogens. Such a strategy could be used to stop the worldwide spread of emergent respiratory diseases, including but not limited to novel strains of influenza.
    MeSH term(s) Animals ; Antigen-Presenting Cells/immunology ; Antigen-Presenting Cells/virology ; Chemokines/metabolism ; Complement C5a/agonists ; Cytokines/metabolism ; Dose-Response Relationship, Drug ; Female ; Humans ; Immunity, Innate/drug effects ; Immunologic Factors/administration & dosage ; Influenza A virus/immunology ; Influenza, Human/immunology ; Influenza, Human/prevention & control ; Insufflation ; Kinetics ; Lung/immunology ; Lung/metabolism ; Lung/pathology ; Lung/virology ; Macrophages, Alveolar/immunology ; Macrophages, Alveolar/virology ; Male ; Mice ; Mice, Inbred C57BL ; Oligopeptides/administration & dosage
    Chemical Substances Chemokines ; Cytokines ; Immunologic Factors ; Oligopeptides ; tyrosyl-seryl-phenylalanyl-lysyl-aspartyl-methionyl-prolyl-N-methyleucyl-alanyl-arginine ; Complement C5a (80295-54-1)
    Language English
    Publishing date 2012-07-06
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0040303
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Innate immune induction and influenza protection elicited by a response-selective agonist of human C5a.

    Sam D Sanderson / Marilyn L Thoman / Kornelia Kis / Elizabeth L Virts / Edgar B Herrera / Stephanie Widmann / Homero Sepulveda / Joy A Phillips

    PLoS ONE, Vol 7, Iss 7, p e

    2012  Volume 40303

    Abstract: ... fungal infection. We have developed a response-selective agonist of human C5a, termed EP67, which retains ... both prophylactic and therapeutic protection when tested in a murine model of influenza A infection. Mice treated ... of innate immune effector cells, including neutrophils, NK cells, and dendritic cells. EP67 exhibits ...

    Abstract The anaphylatoxin C5a is an especially potent mediator of both local and systemic inflammation. However, C5a also plays an essential role in mucosal host defense against bacterial, viral, and fungal infection. We have developed a response-selective agonist of human C5a, termed EP67, which retains the immunoenhancing activity of C5a at the expense of its inflammatory, anaphylagenic properties. EP67 insufflation results in the rapid induction of pulmonary cytokines and chemokines. This is followed by an influx of innate immune effector cells, including neutrophils, NK cells, and dendritic cells. EP67 exhibits both prophylactic and therapeutic protection when tested in a murine model of influenza A infection. Mice treated with EP67 within a twenty-four hour window of non-lethal infection were significantly protected from influenza-induced weight loss. Furthermore, EP67 delivered twenty-four hours after lethal infection completely blocked influenza-induced mortality (0% vs. 100% survival). Since protection based on innate immune induction is not restricted to any specific pathogen, EP67 may well prove equally efficacious against a wide variety of possible viral, bacterial, and fungal pathogens. Such a strategy could be used to stop the worldwide spread of emergent respiratory diseases, including but not limited to novel strains of influenza.
    Keywords Medicine ; R ; Science ; Q
    Subject code 570
    Language English
    Publishing date 2012-01-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top